Advertisement

Electrophysiologic evaluation of facial nerve functions after oxaliplatin treatment

  • Oznur YigitEmail author
  • Mavis Emel Kulak Kayikci
  • Cagri Mesut Temucin
  • Sarp Sarac
  • Mustafa Erman
  • Erol Belgin
Original Article

Abstract

Purpose

This study analyzes the effect of oxaliplatin treatment on the facial nerve. The facial nerve is the most commonly paralyzed cranial motor nerve because it advances through a long, curved bone canal. Electroneurography and blink reflex are the electrophysiological measurements used for evaluating facial nerve function. Oxaliplatin is a cytotoxic agent used in adjuvant or palliative systemic therapy for colorectal cancer treatment.

Methods

This study was performed on 20 individuals who were at least 18 years old at Hacettepe University Ear Nose Throat Department, Audiology and Speech Disorders Unit, and Neurology Division EMG Laboratory as they received oxaliplatin treatment from Hacettepe University Oncology Hospital. Electroneurography and blink-reflex values were recorded and examined. The parameters taken during the second and fourth months were compared for this purpose.

Results

This study shows that the prolongation of distal latencies of compound muscle action potential is statistically significant, the amplitudes showed no difference. The ENoG results were analyzed, the prolongation of latency measurements between pre-treatment and the fourth month after treatment were statistically significant. The blink-reflex results showed that comparison with the baseline values, the prolongation of latencies in R1 measurements between pre-treatment, the second month, and the fourth month were significant.

Conclusions

The facial nerve is affected asymptomatically by oxaliplatin treatment. During oxaliplatin treatment, the evaluation of facial nerve function could be beneficial for patients by improving their quality of life. Electroneurography and blink-reflex tests can be used in the early evaluations of different medicines to determine their neurotoxicity.

Keywords

Polyneuropathy Oxaliplatin Electroneurography Blink reflex 

Notes

Funding

This study was not funded by any entity.

Compliance with ethical standards

Conflict of Interest

Authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Quasthoff S, Hartung HP (2002) Chemotherapy-induced peripheral neuropathy. J Neurol 249(1):9–17CrossRefGoogle Scholar
  2. 2.
    Custodio A, Moreno-Rubio J, Aparicio J, Gallego-Plazas J, Yaya R, Maurel J et al (2013) Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study. Ann Oncol 25(2):398–403CrossRefGoogle Scholar
  3. 3.
    André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23):2343–2351CrossRefGoogle Scholar
  4. 4.
    Lièvre A, Samalin E, Mitry E, Assenat E, Boyer-Gestin C, Lepère C et al (2009) Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study. BMC Cancer. 9(1):347CrossRefGoogle Scholar
  5. 5.
    Cersosimo RJ (2005) Oxaliplatin-associated neuropathy: a review. Ann Pharmacother 39(1):128–135CrossRefGoogle Scholar
  6. 6.
    Esslen E. The acute facial palsies: investigations on the localization and pathogenesis of meato-labyrinthine facial palsies: Springer Science & Business Media; 2012Google Scholar
  7. 7.
    VanSwearingen JM, Cohn JF, Bajaj-Luthra A (1999) Specific impairment of smiling increases the severity of depressive symptoms in patients with facial neuromuscular disorders. Aesthetic Plast Surg 23(6):416–423CrossRefGoogle Scholar
  8. 8.
    Ardic FN, Ardic F, Topaloglu J, Öncel S, Uguz MZ, Topalogu D (1997) Electroneurography in the late period of Bell’s palsy. Acta Otolaryngol 117(3):325–328CrossRefGoogle Scholar
  9. 9.
    Lee KJ (2015) KJ Lee’s essential otolaryngology, 11th edn. McGraw-Hill Education, New YorkGoogle Scholar
  10. 10.
    Ardic F, Ardic F, Topaloglu J, Öncel S, Uguz M, Topalogu D (1997) Electroneurography in the late period of Bell’s palsy. Acta Otolaryngol 117(3):325–328CrossRefGoogle Scholar
  11. 11.
    Akkuzu B (2008) Fasiyal Sinir Hastalıklarında Muayene ve Tanı Teknikleri. Türkiye Klinikleri Kulak Burun Boğaz Özel Dergisi. 1(1):8Google Scholar
  12. 12.
    Hall JWI. Nonauditory clinical neurophysiology. In: D. DS (ed). New handbook of auditory evoked responses. USA: Pearson Education; 2007Google Scholar
  13. 13.
    Cruccu G, Deuschl G (2000) The clinical use of brainstem reflexes and hand-muscle reflexes. Clin Neurophysiol 111(3):371–387CrossRefGoogle Scholar
  14. 14.
    Gültekin M, Boztaş G (2014) Türkiye kanser istatistikleri. Türkiye Halk Sağlığı Kurumu, Sağlık Bakanlığı, p 43Google Scholar
  15. 15.
    Pasetto LM, D’Andrea MR, Rossi E, Monfardini S (2006) Oxaliplatin-related neurotoxicity: how and why? Crit Rev Oncol/Hematol 59(2):159–168CrossRefGoogle Scholar
  16. 16.
    Kannarkat G, Lasher EE, Schiff D (2007) Neurologic complications of chemotherapy agents. Curr Opin Neurol 20(6):719–725Google Scholar
  17. 17.
    Griffith KA, Zhu S, Johantgen M, Kessler MD, Renn C, Beutler AS et al (2017) Oxaliplatin-induced peripheral neuropathy and identification of unique severity groups in colorectal cancer. J Pain Symptom Manag. 54(5):701-6. e1CrossRefGoogle Scholar
  18. 18.
    Pulvers JN, Marx G (2017) Factors associated with the development and severity of oxaliplatin-induced peripheral neuropathy: a systematic review. Asia-Pac J Clin Oncol 13(6):345–355CrossRefGoogle Scholar
  19. 19.
    Akkuzu B (2008) Fasiyal Sinir Hastalıklarında Muayene ve Tanı Teknikleri. Turkiye Klinikleri J Ear Nose Throat-Spec Topics. 1(1):8–13Google Scholar
  20. 20.
    Adelsberger H, Quasthoff S, Grosskreutz J, Lepier A, Eckel F, Lersch C (2000) The chemotherapeutic oxaliplatin alters voltage-gated Na + channel kinetics on rat sensory neurons. Eur J Pharmacol 406(1):25–32CrossRefGoogle Scholar
  21. 21.
    Baba M, Fowler CJ, Jacobs JM, Gilliatt RW (1982) Changes in peripheral nerve fibres distal to a constriction. J Neurol Sci 54(2):197–208CrossRefGoogle Scholar
  22. 22.
    Logician EL, Kelly JJ, Adelman LS (1994) Nerve conduction and biopsy correlation in over 100 consecutive patients with suspected polyneuropathy. Muscle Nerve 17(9):1010–1020CrossRefGoogle Scholar
  23. 23.
    Feinberg DM, Preston DC, Shefner JM, Logigian EL (1999) Amplitude-dependent slowing of conduction in amyotrophic lateral sclerosis and polyneuropathy. Muscle Nerve 22(7):937–940CrossRefGoogle Scholar
  24. 24.
    Lehky TJ, Leonard GD, Wilson RH, Grem JL, Floeter MK (2004) Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy. Muscle Nerve 29(3):387–392CrossRefGoogle Scholar
  25. 25.
    Kazem SS, Behzad D (2006) Role of blink reflex in diagnosis of subclinical cranial neuropathy in diabetic mellitus type II. Am J Phys Med Rehabil 85(5):449–452CrossRefGoogle Scholar
  26. 26.
    Casale R, Frazzitta G, Fundarò C, Balbi P, Rosso AD, Bertinotti L et al (2004) Blink reflex discloses CNS dysfunction in neurologically asymptomatic patients with systemic sclerosis. Clin Neurophysiol 115(8):1917–1920CrossRefGoogle Scholar
  27. 27.
    Cruccu G, Iannetti GD, Marx JJ, Thoemke F, Truini A, Fitzek S et al (2005) Brainstem reflex circuits revisited. Brain 128(2):386–394CrossRefGoogle Scholar
  28. 28.
    Kimura J (1981) Conduction abnormalities of the facial and trigeminal nerves in polyneuropathy. Muscle Nerve 5(9S):S139–S144Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Audiology, Faculty of Health SciencesHacettepe UniversityAnkaraTurkey
  2. 2.Department of Speech and Language Therapy, Faculty of Health SciencesHacettepe UniversityAnkaraTurkey
  3. 3.Department of Neurology, Faculty of MedicineHacettepe UniversityAnkaraTurkey
  4. 4.Department of Ear Nose and Throat, Faculty of MedicineKoc UniversityIstanbulTurkey
  5. 5.Department of Medical Oncology, Faculty of MedicineHacettepe UniversityAnkaraTurkey
  6. 6.Department of Audiology, Faculty of Health SciencesMedipol UniversityIstanbulTurkey

Personalised recommendations